Mechanism of atorvastatin-induced liver injury

ZENG Han-qing,ZHANG Qiong,PENG Wen-xing

2012-01-01

Abstract:Atorvastatin,a 3-hydroxy-3methylglutaryl-coenzmye A(HMG-CoA) reductase inhibitor,is a lipid-lowering drug with good effects on plasma lipids.Atorvastatin can cause dose-dependent increase in serum aminotransferase accompanied by an enlarged liver,jaundice,an increased direct bilirubin level,and a prolonged prothrombin time.The types of atorvastatin-induced liver injury are cytotoxic,cholestatic,and mixed.The mechanism of atorvastatin-induced cytotoxic liver injury may be related to breakage of hepatocyte chromosome DNA and change in hepatocyte morphology by competitive inhibition of HMG-CoA and ultimately causes hepatocyte apoptosis.The mechanism of atorvastatin-induced cholestatic liver injury may be related to the decreased expression or dysfunction of transporter,which located in sinusoidal membrane of hepatocytes and bile duct membrane,or may be related to the inhibited activity of bile salt and bile acid excretion relative transporter protein.The measures of treatment and prevention for atorvastatin-induced liver injury include: before atorvastatin administration,patients'liver function should be tested and the physician should be aware of patients'medical history,other medications,and alcohol habit;it is suggested that atorvastatin should be started at a small dose;if atorvastatin-induced mild-to-moderate increase in aminotransferase occurs,the dosage should be reduced and the patient might receive liver-protective drug;once severe liver injury appears,the drug should be discontinued immediately and symptomatic treatment should be given.